会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Method of increasing expression of heterologous proteins in plants
    • 增加植物中异源蛋白表达的方法
    • US07541515B2
    • 2009-06-02
    • US10252732
    • 2002-09-23
    • Elizabeth HoodJohn HowardDonna Delaney
    • Elizabeth HoodJohn HowardDonna Delaney
    • C12N15/82
    • C12N15/8216C12N15/8257
    • Increased expression of heterologous proteins in a plant is achieved by introducing the nucleotide sequence encoding the heterologous protein into a plant that has high oil seed content compared to low oil seed and/or is introduced into a plant having reduced alcohol soluble proteins in the endosperm. The nucleotide sequence may be introduced by direct transformation into the plant, or by direct transformation into another plant, and crossing with the high oil plant or plant have reduced levels of alcohol soluble protein in the endosperm. Further, the nucleotide sequences may be introduced into one or both of the high oil plant and the plant having reduced levels of alcohol soluble proteins, and the plants may be crossed to result in a progeny having even further increased expression levels of the heterologous protein.
    • 通过将编码异源蛋白质的核苷酸序列引入与低油种子相比具有高油种子含量的植物和/或被引入具有在胚乳中具有降低的可溶性蛋白质的植物中来实现植物中异源蛋白质的表达增加。 核苷酸序列可以通过直接转化到植物中,或通过直接转化到另一种植物中,并与高油植物或植物杂交在胚乳中具有降低的可溶性蛋白质水平。 此外,可以将核苷酸序列引入高油植物和具有降低的可溶性蛋白质水平的植物中的一个或两个中,并且可以使植物杂交以产生具有甚至进一步增加异源蛋白质表达水平的后代。
    • 6. 发明授权
    • Ultrasound enhancement of drug release across non-ionic surfactant membranes
    • 通过非离子表面活性剂膜超声增强药物释放
    • US07981442B2
    • 2011-07-19
    • US11427034
    • 2006-06-28
    • Elizabeth HoodJoel A. StromMichael VanAuker
    • Elizabeth HoodJoel A. StromMichael VanAuker
    • A61K9/127A61K9/48
    • A61K9/1272A61K9/0009A61K41/0028A61K49/0002
    • A method of targeted drug delivery and imaging using nonionic surfactant vesicles (niosomes) in combination with ultrasound. Niosomes have potential applications in targeted drug delivery and imaging because of their ability to encapsulate therapeutic agents and their enhanced uptake by physiological membranes. Ultrasound may be used to mediate delivery non-invasively by altering the niosome membrane structure. Niosomes composed of polyoxyethylene sorbitan monostearate (Tween 61), cholesterol, and dicetyl phosphate were synthesized via a thin film hydration technique and used for encapsulation studies. Carboxyfluorescein dye (CF) was used as a drug model to demonstrate delivery. The amount of dye in the niosomes, the concentration of the vesicles, and their mean particle size after each 5 minute incremental exposure to ultrasound was monitored. Dye concentration in niosome samples decreased while the population and size distribution of the niosome remained largely unchanged. Ultrasound is demonstrated to enhance the rate of dye diffusion across the niosome membrane non-destructively.
    • 使用非离子表面活性剂囊泡(niosomes)与超声波组合的靶向药物递送和成像的方法。 Niosomes由于其能够包封治疗剂和增强生理膜吸收的能力,在靶向药物递送和成像中具有潜在应用。 超声波可用于通过改变niosome膜结构非侵入性地介导递送。 通过薄膜水合技术合成由聚氧乙烯脱水山梨醇单硬脂酸酯(吐温61),胆固醇和磷酸二鲸蜡酯组成的纳米粒子,用于封装研究。 使用羧基荧光素染料(CF)作为药物模型来证明递送。 监测niosomes中的染料量,囊泡浓度及每5分钟增加暴露于超声波后的平均粒径。 niosome样品中的染料浓度下降,而niosome的人口和大小分布基本保持不变。 证明超声可以非破坏性地提高染色体在染色体膜上的扩散速率。
    • 7. 发明申请
    • Ultrasound Enhancement of Drug Release Across Non-Ionic Surfactant Membranes
    • 超声增强非离子表面活性剂膜上的药物释放
    • US20060292211A1
    • 2006-12-28
    • US11427034
    • 2006-06-28
    • Elizabeth HoodJoel StromMichael VanAuker
    • Elizabeth HoodJoel StromMichael VanAuker
    • A61K9/127
    • A61K9/1272A61K9/0009A61K41/0028A61K49/0002
    • A method of targeted drug delivery and imaging using nonionic surfactant vesicles (niosomes) in combination with ultrasound. Niosomes have potential applications in targeted drug delivery and imaging because of their ability to encapsulate therapeutic agents and their enhanced uptake by physiological membranes. Ultrasound may be used to mediate delivery non-invasively by altering the niosome membrane structure. Niosomes composed of polyoxyethylene sorbitan monostearate (Tween 61), cholesterol, and dicetyl phosphate were synthesized via a thin film hydration technique and used for encapsulation studies. Carboxyfluorescein dye (CF) was used as a drug model to demonstrate delivery. The amount of dye in the niosomes, the concentration of the vesicles, and their mean particle size after each 5 minute incremental exposure to ultrasound was monitored. Dye concentration in niosome samples decreased while the population and size distribution of the niosome remained largely unchanged. Ultrasound is demonstrated to enhance the rate of dye diffusion across the niosome membrane non-destructively.
    • 使用非离子表面活性剂囊泡(niosomes)与超声波组合的靶向药物递送和成像的方法。 Niosomes由于其能够包封治疗剂和增强生理膜吸收的能力,在靶向药物递送和成像中具有潜在应用。 超声波可用于通过改变niosome膜结构非侵入性地介导递送。 通过薄膜水合技术合成由聚氧乙烯脱水山梨醇单硬脂酸酯(吐温61),胆固醇和磷酸二鲸蜡酯组成的纳米粒子,用于封装研究。 使用羧基荧光素染料(CF)作为药物模型来证明递送。 监测niosomes中的染料量,囊泡浓度及每5分钟增加暴露于超声波后的平均粒径。 niosome样品中的染料浓度下降,而niosome的人口和大小分布基本保持不变。 证明超声可以非破坏性地提高染色体在染色体膜上的扩散速率。